Hudson Bay Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Hudson Bay Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,900	Closed	-$301K	–	1558
2025 Q4	$301K	Buy	+8,900	New	+$276K	﹤0.01%	919

Hudson Bay Capital Management's RAPT Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 8,900 shares — an estimated $301K sold.

Hudson Bay Capital Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $301K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Hudson Bay Capital Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 8,900 RAPT Therapeutics shares in Q1 2026, an estimated $301K.
Hudson Bay Capital Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Hudson Bay Capital Management's RAPT Therapeutics position peaked at $301K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.